Effect of Neutrophil Priming on Chemotaxis and Signaling

中性粒细胞启动对趋化性和信号传导的影响

• 批准号: 7525773
• 负责人: Jonathan S Reichner
• 金额: $ 29.27万
• 依托单位: RHODE ISLAND HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-05-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7525773
• 关键词: Affect; Age; Agonist; Arthritis; Autoimmune Diseases; Binding; Binding Sites; Biological; Blood; Blood Circulation; CD18 Antigens; Cancer Patient; Carbohydrates; Cell Adhesion Molecules; Cell Surface Receptors; Cell Wall; Cells; Chemotaxis; Complement; Complex; Condition; Cytoplasmic Tail; DNA Sequence Rearrangement; Development; Emigrations; Endothelial Cells; Extracellular Matrix; Failure; Family; Fluorescence Resonance Energy Transfer; Funding; Fungal Components; Glucans; Healed; Host Defense; Hyperactive behavior; ITGAM gene; Immune response; Immune system; Immunosuppression; Impaired wound healing; Infection; Infection prevention; Inflammation; Inflammatory; Inflammatory Bowel Diseases; Inflammatory Response; Injury; Inositol; Integrins; Laboratory Study; Lead; Lectin; Leukocytes; Life; Ligand Binding; Ligand Binding Domain; Ligation; Location; Macrophage-1 Antigen; Mammalian Cell; Measures; Mediating; Molecular; Molecular Conformation; Multiple Sclerosis; Numbers; Pathology; Pattern; Pattern recognition receptor; Play; Process; Psoriasis; Public Health; Recurrence; Regulation; Role; Sepsis; Signal Pathway; Signal Transduction; Signal Transduction Pathway; Site; Spottings; Structure; Therapeutic immunosuppression; Thinking; Time; Tissues; Trauma; Work; Wound Healing; antimicrobial; beta-Glucans; healing; human migration; improved; in vivo; innovation; microbial host; neutrophil; novel therapeutics; pathogen; peripheral blood; receptor; research study; response; response to injury; therapeutic target

DESCRIPTION (provided by applicant): The emigration of peripheral blood neutrophils to a site of infection includes a central role of integrins within the beta-2 family. Neutrophils use these integrins to adhere to endothelial cells located in the vicinity of infection and subsequently to extracellular matrix in order to guide their navigation towards the pathogen. The beta-2 integrin CR3 (CD11b/CD18) is a unique receptor in that it has two distinct ligand binding sites, the I-domain which recognizes cell adhesion molecules, complement components and extracellular matrix; and the lectin domain which binds carbohydrate such as beta-glucan and those expressed on glycosylphosphatidyl inositol-anchored receptors. Beta-glucan is a polymer of glucose moieties in (1,3)(1,6)-beta-D-linkages found normally as a structural component of the fungal cell wall and is a functional agonist of the CR3 lectin site. During the current funding period we found than a number of CR3-dependent neutrophil functions are regulated differently in response to ligation of the I-domain, the lectin site, or both together. Experiments are proposed in this continuation to determine the mechanism/s that explain how a single receptor can transduce such different cellular affects when ligated at its distinct binding sites. The specific aims of this proposal are: (I) to determine the dynamic regulation and spatial localization of CR3 upon differential activation of the I-domain and the lectin site; (II) to determine the signal transduction pathways that mediate the conversion of random to directed migration of human neutrophils upon activation of the CR3 lectin site; (III) to determine the role of CR3 lectin site activation on host defense in vivo. Given the importance of CR3 in every aspect of leukocyte function, a better understanding of the complex regulatory mechanisms that control its function may lead to better treatment of the pathological conditions that result from its dysregulation. Hyperactivity can lead to pathologies such as autoimmune diseases, multiple sclerosis, inflammatory bowel disease, psoriasis, and arthritis. Insufficient function can result in recurrent infection and failure to heal wounds. Therapies that target CR3 may be developed to safely and effectively enhance leukocyte function in presurgical or cancer patients or those following trauma, sepsis, wounding, aging or immunosuppression. The underlying premise of this proposal is that a better understanding of leukocyte integrin regulation may reveal that integrins represent therapeutic targets for safe and effective regulation of the innate immune system. PUBLIC HEALTH RELEVANCE: Inflammation is an essential response to injury or infection as it prevents infections from becoming widespread and begins the process of healing. White blood cells (leukocytes) circulate continuously in the bloodstream but in response to a local site of injury, they must emigrate from the blood into the damaged tissue to begin healing. The focus of this proposal is to help determine how circulating white blood cells sense the location of a tissue injury and migrate directly to the exact spot. Cell surface receptors known as integrins are necessary for leukocytes to navigate properly and are the subject of this proposal.

描述（由申请方提供）：外周血中性粒细胞迁移至感染部位包括β-2家族内整合素的核心作用。嗜中性粒细胞利用这些整合素粘附于位于感染附近的内皮细胞，随后粘附于细胞外基质，以引导它们向病原体导航。β-2整联蛋白CR 3（CD 11b/CD 18）是一种独特的受体，因为它具有两个不同的配体结合位点，即识别细胞粘附分子、补体成分和细胞外基质的I-结构域;以及结合碳水化合物（如β-葡聚糖）和糖基磷脂酰肌醇锚定受体上表达的那些的凝集素结构域。β-葡聚糖是（1，3）（1，6）-β-D-键中葡萄糖部分的聚合物，通常作为真菌细胞壁的结构组分，是CR 3凝集素位点的功能性激动剂。在目前的资助期间，我们发现许多依赖CR 3的中性粒细胞功能在响应I结构域、凝集素位点或两者一起的连接时受到不同的调节。在本续中提出了实验来确定解释单个受体如何在其不同的结合位点连接时能够抑制这种不同的细胞效应的机制。本发明的具体目的是：（I）确定CR 3在I-结构域和凝集素位点的差异活化时的动态调节和空间定位;（II）确定介导人中性粒细胞在CR 3凝集素位点活化时从随机迁移转化为定向迁移的信号转导途径;（III）确定CR 3凝集素位点激活对宿主体内防御的作用。考虑到CR 3在白细胞功能的各个方面的重要性，更好地理解控制其功能的复杂调节机制可能会导致更好地治疗由其失调引起的病理状况。活动过度可导致诸如自身免疫性疾病、多发性硬化症、炎性肠病、牛皮癣和关节炎的病理。功能不足可能导致复发性感染和伤口愈合失败。可以开发靶向CR 3的疗法，以安全有效地增强术前或癌症患者或创伤、败血症、创伤、衰老或免疫抑制后患者的白细胞功能。该建议的基本前提是，更好地理解白细胞整合素调节可能揭示整合素代表先天免疫系统安全有效调节的治疗靶点。公共卫生相关性：炎症是对损伤或感染的基本反应，因为它可以防止感染蔓延并开始愈合过程。白色血细胞（白细胞）在血流中连续循环，但为了响应局部损伤部位，它们必须从血液中迁移到受损组织中以开始愈合。这项建议的重点是帮助确定循环的白色血细胞如何感知组织损伤的位置并直接迁移到确切的位置。细胞表面受体被称为整合素是白细胞正确导航所必需的，也是本提案的主题。